Direct-acting antiviral therapy immediately after liver transplant in naïve or NS5A-relapser recipients. Issue 1 (February 2018) - Martini, S.; Chialà, C.; Calvo, F.; Tandoi, F.; Patrono, D.; Cocchis, D.; Ottobrelli, A.; Salizzoni, M.; Saracco, G.M.; Romagnoli, R.